189 related articles for article (PubMed ID: 28639896)
1. SGK2 promotes hepatocellular carcinoma progression and mediates GSK-3β/β-catenin signaling in HCC cells.
Liu J; Zhang G; Lv Y; Zhang X; Ying C; Yang S; Kong X; Yu Y
Tumour Biol; 2017 Jun; 39(6):1010428317700408. PubMed ID: 28639896
[TBL] [Abstract][Full Text] [Related]
2. [Serum-and-glucocorticoid-inducible-kinase-2 is overexpressed and mediates glycogen synthase kinase-3β/ β-catenin signal transduction in hepatocellular carcinoma].
Liu JY; Kong X; Li H; Fan GL; Liu Y; Liang ZL; Wang LH; Zhang Y; Zhao Y; Fan YM; Wu B
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):43-46. PubMed ID: 32023698
[No Abstract] [Full Text] [Related]
3. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
4. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
5. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
Jiang J; Xu B; Zheng Y; Guo X; Chen F
Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
[TBL] [Abstract][Full Text] [Related]
6. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
Lan Y; Han J; Wang Y; Wang J; Yang G; Li K; Song R; Zheng T; Liang Y; Pan S; Liu X; Zhu M; Liu Y; Meng F; Mohsin M; Cui Y; Zhang B; Subash S; Liu L
Cell Death Dis; 2018 Feb; 9(2):236. PubMed ID: 29445189
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/β-catenin signaling pathway.
Guo Y; Chen L; Sun C; Yu C
Biomed Pharmacother; 2017 Jul; 91():13-20. PubMed ID: 28437633
[TBL] [Abstract][Full Text] [Related]
9. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.
Cervello M; Augello G; Cusimano A; Emma MR; Balasus D; Azzolina A; McCubrey JA; Montalto G
Adv Biol Regul; 2017 Aug; 65():59-76. PubMed ID: 28619606
[TBL] [Abstract][Full Text] [Related]
10. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
[TBL] [Abstract][Full Text] [Related]
11. HMGA1 participates in MHCC97H cell proliferation and invasion through the ILK/Akt/GSK3β signaling pathway.
Liu L; Zhang S; Hu L; Liu L; Guo W; Zhang J
Mol Med Rep; 2017 Dec; 16(6):9287-9294. PubMed ID: 29152644
[TBL] [Abstract][Full Text] [Related]
12. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
Liu F; Wu X; Jiang X; Qian Y; Gao J
J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988
[TBL] [Abstract][Full Text] [Related]
13. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways.
Kong X; Liu F; Gao J
Oncotarget; 2016 Oct; 7(40):66051-66060. PubMed ID: 27602769
[TBL] [Abstract][Full Text] [Related]
14. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase.
Kobayashi T; Deak M; Morrice N; Cohen P
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):189-97. PubMed ID: 10548550
[TBL] [Abstract][Full Text] [Related]
16. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
[TBL] [Abstract][Full Text] [Related]
17. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
18. Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway.
Kong X; Peng H; Liu P; Fu X; Wang N; Zhang D
Cancer Sci; 2023 Jun; 114(6):2265-2276. PubMed ID: 36751987
[TBL] [Abstract][Full Text] [Related]
19. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
[TBL] [Abstract][Full Text] [Related]
20. SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling.
Chen J; Chan AW; To KF; Chen W; Zhang Z; Ren J; Song C; Cheung YS; Lai PB; Cheng SH; Ng MH; Huang A; Ko BC
Hepatology; 2013 Jun; 57(6):2287-98. PubMed ID: 23348706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
